Centene Co. (NYSE:CNC – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors purchased 9,358 put options on the company. This is an increase of 126% compared to the average volume of 4,133 put options.
Centene Stock Performance
Shares of NYSE CNC opened at $72.67 on Friday. The stock has a market capitalization of $38.78 billion, a PE ratio of 14.45, a price-to-earnings-growth ratio of 1.06 and a beta of 0.50. Centene has a 52 week low of $62.50 and a 52 week high of $81.42. The stock has a 50 day moving average price of $72.80 and a 200 day moving average price of $73.90. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.17 and a current ratio of 1.17.
Centene (NYSE:CNC – Get Free Report) last issued its earnings results on Friday, July 26th. The company reported $2.42 earnings per share for the quarter, missing analysts’ consensus estimates of $2.44 by ($0.02). The firm had revenue of $39.84 billion for the quarter, compared to analyst estimates of $36.83 billion. Centene had a return on equity of 14.45% and a net margin of 1.79%. Centene’s quarterly revenue was up 5.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.10 earnings per share. Analysts predict that Centene will post 6.84 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Centene
Analyst Ratings Changes
CNC has been the topic of a number of analyst reports. StockNews.com raised Centene from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 29th. JPMorgan Chase & Co. lowered their price target on Centene from $85.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, July 10th. TD Cowen upped their target price on shares of Centene from $80.00 to $89.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. Barclays decreased their price target on shares of Centene from $98.00 to $97.00 and set an “overweight” rating for the company in a report on Thursday. Finally, Jefferies Financial Group downgraded Centene from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $83.00 to $69.00 in a research note on Wednesday, July 24th. Seven investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Centene presently has a consensus rating of “Moderate Buy” and an average target price of $85.75.
Get Our Latest Analysis on Centene
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Read More
- Five stocks we like better than Centene
- Investing in Construction Stocks
- Emerging Markets: What They Are and Why They Matter
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Recession or Not, These 3 Stocks Are Winners
- Manufacturing Stocks Investing
- Why NVIDIA Is More of a Screaming Buy Than Ever
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.